Whipplewood Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160K Sell
319
-102
-24% -$49K 0.11% 103
2026
Q1
$207K Buy
421
+123
+41% +$66.8K 0.11% 125
2025
Q4
$173K Buy
298
+3
+1% +$1.7K 0.11% 132
2025
Q3
$143K Sell
295
-231
-44% -$108K 0.09% 140
2025
Q2
$213K Sell
526
-32
-6% -$13.4K 0.12% 158
2025
Q1
$299K Sell
558
-23
-4% -$12.5K 0.18% 116
2024
Q4
$302K Buy
+581
New +$319K 0.17% 118

Other funds holding TMO

Whipplewood Advisors's TMO Position: Q2 2026 in Review

Whipplewood Advisors reduced its Thermo Fisher Scientific (TMO) stake by 24% in Q2 2026, selling an estimated $49K and leaving 319 shares worth $160K. The position accounts for 0.11% of the portfolio, ranked #103.

Whipplewood Advisors first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $302K in Q4 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Whipplewood Advisors held 319 shares of Thermo Fisher Scientific worth $160K as of Q2 2026.
  • Whipplewood Advisors sold 102 Thermo Fisher Scientific shares in Q2 2026, an estimated $49K.
  • Thermo Fisher Scientific made up 0.11% of Whipplewood Advisors's portfolio in Q2 2026, its #103 holding.
  • Whipplewood Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Whipplewood Advisors's Thermo Fisher Scientific position peaked at $302K in Q4 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.